WallStreetZenWallStreetZen

NASDAQ: NRIX
Nurix Therapeutics Inc Stock Ownership - Who owns Nurix Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nurix Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Gwenn HansenCSci2026-10-151,452$1.86
$2.70kBuy
Gwenn HansenCSci2026-10-151,452$25.00
$36.30kSell
Julia P. GregoryDirector2026-10-1422,583$23.40
$528.53kSell
Julia P. GregoryDirector2026-10-1422,583$1.86
$42.00kBuy
Christine RingCLO2026-10-025,786$8.72
$50.45kBuy
Christine RingCLO2026-10-025,786$23.19
$134.15kSell
Christine RingCLO2026-09-02400$26.64
$10.65kSell
Christine RingCLO2026-09-025,387$25.70
$138.42kSell
Christine RingCLO2026-09-025,787$8.72
$50.46kBuy
Gwenn HansenCSci2026-09-011,452$1.86
$2.70kBuy

1 of 6

NRIX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NRIX insiders and whales buy or sell their stock.

NRIX Shareholders

What type of owners hold Nurix Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures III LP3.21%3,509,348$85.70MInsider
Column Group L P1.90%2,080,607$50.81MInsider
Redmile Group LLC1.08%1,176,470$28.73MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP0.72%784,313$19.15MInsider
Arthur T. Sands0.42%458,333$11.19MInsider
Robert Tjian0.11%124,999$3.05MInsider
Pierre Beaurang0.11%120,996$2.95MInsider
Gwenn Hansen0.11%117,227$2.86MInsider
Houte Hans Van0.04%40,166$980.85kInsider
David L. Lacey0.03%33,333$813.99kInsider

1 of 3

NRIX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NRIX0.11%7.75%Net SellingNet Selling
DYN0.10%20.12%Net SellingNet Selling
ZLAB0.00%1.78%Net BuyingNet Selling
ELVN0.11%80.98%Net SellingNet Selling
CELC0.12%22.15%Net SellingNet Buying
View Top Biotech Stocks

Nurix Therapeutics Stock Ownership FAQ

Who owns Nurix Therapeutics?

Nurix Therapeutics (NASDAQ: NRIX) is owned by 0.11% institutional shareholders, 7.75% Nurix Therapeutics insiders, and 92.14% retail investors. Third Rock Ventures III LP is the largest individual Nurix Therapeutics shareholder, owning 3.51M shares representing 3.21% of the company. Third Rock Ventures III LP's Nurix Therapeutics shares are currently valued at $85.70M.

If you're new to stock investing, here's how to buy Nurix Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.